Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03414528
  4. Details
NCT03414528 Clinical Trial

Identification of New Inborn Errors of Immunity

Primary Immune Deficiency Disorder Clinical Trial

Official title:
Towards Identification of New Inborn Errors of Immunity by Whole Exome/Genome Sequencing

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03414528
Other study ID # Ident_PID
Secondary ID
Status Recruiting
Phase N/A
First received January 10, 2018
Last updated January 22, 2018
Start date August 15, 2015
Est. completion date August 15, 2025

Study information
Verified date January 2018
Source University of Zurich
Contact Janine Reichenbach, Prof. Dr.
Phone +41442667311
Email janine.reichenbach@kispi.uzh.ch
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Analysis of DNA samples of patients with molecularly undetermined PID by whole exome/genome sequencing.

Transcriptome analysis of patients with molecularly undetermined PID.

Recruitment information / eligibility
Status Recruiting
Enrollment 300
Est. completion date August 15, 2025
Est. primary completion date August 15, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients with primary immunodeficiency (PID)

- Male and Female participants 0 years to adult age (any)

- Written informed consent by the participant after information about the research project

Exclusion Criteria:

- Secondary immunodeficiency

- Refusal to enter the study

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Diagnostic Test
Analysis of DNA samples of patients with molecularly undetermined PID by whole exome/genome sequencing Transcriptome analysis of patients with molecularly undetermined PID

Locations
Country Name City State
Switzerland University Children's Hospital Zurich Zurich

Sponsors (1)
Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Identification of the genetic defects Whole exome/Genome sequencing will be done to identify new mutations leading to immunodeficiency 10 years
See also
  Status Clinical Trial Phase
Completed NCT03939533 - Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases Phase 3
Recruiting NCT03266627 - Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection Phase 2
Recruiting NCT03266640 - Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) Phase 2
Completed NCT01859754 - Octagam 5% Versus Comparator Post Marketing Trial
Recruiting NCT03148028 - Immunological Characteristics of Patients With PID and IBD N/A
Active, not recruiting NCT04354818 - Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
Completed NCT03988426 - Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases Phase 3
Completed NCT01888484 - Study of Octanorm Subcutaneous IG in Patients With PID Phase 3
Completed NCT01131858 - Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency Phase 1/Phase 2
Completed NCT03211689 - The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease N/A
Terminated NCT01883921 - Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
Recruiting NCT03266653 - EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection Phase 2
Completed NCT02327351 - TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID Phase 2/Phase 3
Completed NCT03618147 - Primary Immunodeficiency in Kuwait
Recruiting NCT04197596 - Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) Phase 1/Phase 2
Recruiting NCT03422614 - Pathophysiology of Inborn Immunodeficiencies N/A
Completed NCT02888535 - Intensive Care Unit and Secondary and Primary Immune Deficiency
Recruiting NCT04232085 - Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide Phase 2
Active, not recruiting NCT03037359 - A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products
Completed NCT03069079 - Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study N/A